US Patent 8324199 Pyridazine derivatives as factor xia inhibitors
Patent 8324199 was granted and assigned to Bristol-Myers Squibb on December, 2012 by the United States Patent and Trademark Office.
All edits
Edits on 19 Jun, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 15 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08324199 Pyridazine derivatives as factor xia inhibitors US Patent 8324199 Pyridazine derivatives as factor xia inhibitors
Infobox
Patent Number
0832419900
Patent Number
832419900
Edits on 23 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
083241990
Date of Patent
December 4, 2012
0Patent Application Number
129211770
Date Filed
March 12, 2009
0Patent Primary Examiner
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
083241990
Date of Patent
December 4, 2012
0Patent Application Number
129211770
Date Filed
March 12, 2009
0Patent Primary Examiner
Edits on 15 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08324199 Pyridazine derivatives as factor xia inhibitors
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08324199
Date of patent
December 4, 2012
Patent application number
12921177
Date Filed
March 12, 2009
Patent primary examiner
Find more entities like US Patent 8324199 Pyridazine derivatives as factor xia inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.